Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy

Dig Liver Dis. 2014 May;46(5):427-32. doi: 10.1016/j.dld.2014.01.003. Epub 2014 Feb 16.

Abstract

Background: The natural history of chronic hepatitis B is variable. We evaluated some of the risk factors for cirrhosis, hepatocellular carcinoma and liver-related mortality in Italian patients with chronic hepatitis B.

Methods: A cohort of 105 untreated patients with chronic hepatitis B without cirrhosis at diagnosis was followed prospectively for a mean period of 23 years. Clinical, histological and ultrasound examinations, biochemical and virological tests, and causes of death were analyzed.

Results: Forty-two (40%) patients became inactive carriers and 63 (60%) showed persistent alanine aminotransferase elevation: 13 (13%) associated with HBeAg persistence, 35 (33%) with detectable serum HBV-DNA but HBeAg-negative, 11 (10%) with concurrent virus infection and 4 (4%) with non-alcoholic fatty liver disease. Cirrhosis incidence was 1.56/100 person-years. Older age and sustained HBV replication predicted cirrhosis occurrence independently. Hepatocellular carcinoma incidence was 2.1/100 person-years in patients who developed cirrhosis and 0.06 in those who did not. Cirrhosis occurrence was associated with an increased risk of hepatocellular carcinoma (hazard ratio 20.4, 95% confidence interval 2.54-167.5) and liver-related death (16.5, 2.0-138.8).

Conclusions: In Italian patients with chronic hepatitis B cirrhosis strongly predicts hepatocellular carcinoma occurrence and disease-related mortality, thus indicating that early antiviral treatment should be instituted before cirrhosis occurrence.

Keywords: Chronic hepatitis B; Cirrhosis; Hepatocellular carcinoma; Liver-related mortality; Natural history.

MeSH terms

  • Adult
  • Age Factors
  • Alanine Transaminase / blood
  • Carcinoma, Hepatocellular / mortality*
  • Carcinoma, Hepatocellular / virology
  • Carrier State / blood
  • Carrier State / virology
  • DNA, Viral / blood
  • Disease Progression
  • Female
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology*
  • Hepatitis B virus / physiology
  • Hepatitis B, Chronic / blood
  • Hepatitis B, Chronic / genetics
  • Hepatitis B, Chronic / mortality*
  • Hepatitis C Antibodies / blood
  • Hepatitis D / immunology
  • Humans
  • Incidence
  • Interleukins / genetics
  • Italy / epidemiology
  • Liver Cirrhosis / mortality*
  • Liver Cirrhosis / virology
  • Liver Neoplasms / mortality*
  • Liver Neoplasms / virology
  • Longitudinal Studies
  • Male
  • Prospective Studies
  • Risk Factors
  • Virus Replication

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Hepatitis C Antibodies
  • interferon-lambda, human
  • Interleukins
  • Alanine Transaminase